Drug Shortage Report for CELESTONE SOLUSPAN

Last updated on 2023-01-25 History
Report ID 182289
Drug Identification Number 00028096
Brand name CELESTONE SOLUSPAN
Common or Proper name BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID
Company Name ORGANON CANADA INC.
Market Status MARKETED
Active Ingredient(s) BETAMETHASONE BETAMETHASONE ACETATE
Strength(s) 3MG 3MG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRADERMAL INTRABURSAL INTRA-ARTICULAR INTRAMUSCULAR INTRADERMAL INTRABURSAL INTRA-ARTICULAR
Packaging size 1ML VIAL
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-03-31
Actual start date
Estimated end date 2023-05-26
Actual end date
Shortage status Anticipated shortage
Updated date 2023-01-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 16766 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-844-820-5468 dpoc.canada@organon.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2023-01-25 French Compare
v1 2023-01-25 English Compare

Showing 1 to 2 of 2